bioRxiv Science⌕ Search

Biology subjects

Balasubramanian, G.

Publications and source records attributed to Balasubramanian, G..

2 recordsLinked to original sources

Dynamic strategic social learning in nest-building zebra finches and its generalisability

Animals often balance asocial and social information strategically, adjusting when and from whom they copy based on context. Yet the cognition driving this dynamic--and its broader implications--remains poorly understood. We tested whether zebra finches use a copy-if-dissatisfied strategy by manipulating the quality of their initial nest-building or reproductive experience, showing them a conspecific nest-builder, and tracking subsequent material choices. Builder-males were more likely to choose the demon-strated social material--particularly at first choice--if they had previously used low-quality material. Using cognitive modelling, we estimated how latent learning mechanisms shaped decisions, identifying two asocial and two social parameters. These estimates provide the first formal evidence for the cognitive basis of nest building. Forward simulations informed--but not predetermined--by these parameters approximated observed behaviour, supporting their causal role. We then used these parameters in exploratory simulations to test how choices might shift under novel payoff contexts. We found that payoff structure--not (dis)satisfaction--was the primary driver of social material use, though higher rewards did not proportionally increase copying. These exploratory simulation results offer preliminary insight into mechanisms underlying material-use variation. Our study illustrates how computational modelling can robustly link behaviour to underlying learning mechanisms and probe the generalisability of animal cognition--a rarity in this field.

animal behavior and cognition↗

BindingSiteAugmentedDTA: Enabling A Next-Generation Pipeline for Interpretable Prediction Models in Drug-Repurposing

While research into Drug-Target Interaction (DTI) prediction is fairly mature, generalizability and interpretability are not always addressed in the existing works in this field. In this paper, we propose a deep learning-based framework, called BindingSite-AugmentedDTA, which improves Drug-Target Affinity (DTA) predictions by reducing the search space of potential binding sites of the protein, thus making the binding affinity prediction more efficient and accurate. Our BindingSite-AugmentedDTA is highly generalizable as it can be integrated with any DL-based regression model, while it significantly improves their prediction performance. Also, unlike many existing models, our model is highly interpretable due to its architecture and self-attention mechanism, which can provide a deeper understanding of its underlying prediction mechanism by mapping attention weights back to protein binding sites. The computational results confirm that our framework can enhance the prediction performance of seven state-of-the-art DTA prediction algorithms in terms of 4 widely used evaluation metrics, including Concordance Index (CI), Mean Squared Error (MSE), modified squared correlation coefficient [Formula], and the Area Under the Precision Curve (AUPC). We also contribute to the two most commonly used DTA benchmark datasets, namely Kiba and Davis, by including additional information on 3D structure of all proteins contained in these two datasets. We manually extracted this information from Protein Data Bank (PDB) files of proteins available at https://www.uniprot.org/. Furthermore, we experimentally validate the practical potential of our proposed framework through in-lab experiments. We measure the binding interaction between several drug candidate compounds for the inhibition of binding between (SARS-CoV-2 S-protein RBD) Spike and ACE-2 (host cell binding target) proteins. We then compare the computationally-predicted results against the ones experimentally-observed in the laboratory. The relatively high agreement between computationally-predicted and experimentally-observed binding interactions supports the potential of our framework as the next-generation pipeline for prediction models in drug repurposing.

bioinformatics↗